Pfizer to Seek Approval for 3rd COVID Shot in Children

Published on April 14, 2022

Pfizer and BioNTech are making progress in their quest to approve a third dose of their Covid vaccine for children aged five through 11. Think of it like adding an extra layer of protection to a suit of armor! The companies have announced positive results from a clinical trial, showing that the third shot is safe and elicits an immune response in this age group. Now, they’re taking the next step and seeking regulatory authorization for the vaccine. This exciting development could mean even more kids can stay healthy and protected against the virus. If approved, it would be another crucial tool in the ongoing battle against Covid. Stay tuned for updates as the process continues! To learn more about this breakthrough research, check out the full article.

Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>